Acetylcysteine as adjuvant therapy for vasculitis associated with antineutrophil cytoplasmic antibody

Journal of Rheumatology

Volumn 38, Issue 4, 2011, Pages 785-

  Fernández Fernández, Francisco José ^a   Sesma, Pascual ^a  

^a Universidad de La Coruña   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; GLUTATHIONE; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PLACEBO; PREDNISONE; RITUXIMAB;

ADJUVANT THERAPY; ANCA ASSOCIATED VASCULITIS; BONE MARROW TOXICITY; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LETTER; LUNG CAVITATION; MAINTENANCE THERAPY; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; RELAPSE; REMISSION; RESPIRATORY TRACT DISEASE; UPPER RESPIRATORY TRACT; WEGENER GRANULOMATOSIS;

ACETYLCYSTEINE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; FREE RADICAL SCAVENGERS; HUMANS; MALE; MIDDLE AGED; VASCULITIS;

EID: 79953325692     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101159     Document Type: Letter

References (9)

1. Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al, for the European Vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010;363:211-20.
2. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al, for the RAVE-INT Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010;363:221-32.
3. Seo P, Specks U, Keogh KA. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations. J Rheumatol 2008;35:2017-23.
4. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, et al, for the IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-42. (Pubitemid 41697286)
5. Hunninghake GW. Antioxidant therapy for idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2285-7. (Pubitemid 41699756)
6. Qasim FJ, Mathieson PW, Thiru S, Oliveira DB. Use of methyl predisolone and antioxidants in mercuric chloride-induced experimental vasculitis. Clin Exp Immunol 1994;98:66-70. (Pubitemid 24315453)
7. Wu Z, Turner DR, Oliveira DB. Antioxidants inhibit mercuric chloride-induced early vasculitis. Int Immunol 2002;14:267-73. (Pubitemid 34213638)
8. Little MA, Smyth L, Salama AD, Mukherjee S, Smith J, Haskard D, et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol 2009;174:1212-20.
9. Guilpain P, Servettaz A, Batteux F, Guillevin L, Mouthon L. Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies. Autoimmun Rev 2008;7:421-5.